Skip to main content
Top
Published in: Journal of Inherited Metabolic Disease 5/2014

01-09-2014 | Original Article

Unravelling the complex MRI pattern in glutaric aciduria type I using statistical models—a cohort study in 180 patients

Authors: Sven F. Garbade, Cheryl R. Greenberg, Mübeccel Demirkol, Gülden Gökçay, Antonia Ribes, Jaume Campistol, Alberto B. Burlina, Peter Burgard, Stefan Kölker

Published in: Journal of Inherited Metabolic Disease | Issue 5/2014

Login to get access

Abstract

Background

Glutaric aciduria type I (GA-I) is a cerebral organic aciduria caused by inherited deficiency of glutaryl-CoA dehydrogenase and is characterized biochemically by an accumulation of putatively neurotoxic dicarboxylic metabolites. The majority of untreated patients develops a complex movement disorder with predominant dystonia during age 3–36 months. Magnetic resonance imaging (MRI) studies have demonstrated striatal and extrastriatal abnormalities.

Aims/methods

The major aim of this study was to elucidate the complex neuroradiological pattern of patients with GA-I and to associate the MRI findings with the severity of predominant neurological symptoms. In 180 patients, detailed information about the neurological presentation and brain region-specific MRI abnormalities were obtained via a standardized questionnaire.

Results

Patients with a movement disorder had more often MRI abnormalities in putamen, caudate, cortex, ventricles and external CSF spaces than patients without or with minor neurological symptoms. Putaminal MRI changes and strongly dilated ventricles were identified as the most reliable predictors of a movement disorder. In contrast, abnormalities in globus pallidus were not clearly associated with a movement disorder. Caudate and putamen as well as cortex, ventricles and external CSF spaces clearly collocalized on a two-dimensional map demonstrating statistical similarity and suggesting the same underlying pathomechanism.

Conclusions

This study demonstrates that complex statistical methods are useful to decipher the age-dependent and region-specific MRI patterns of rare neurometabolic diseases and that these methods are helpful to elucidate the clinical relevance of specific MRI findings.
Appendix
Available only for authorised users
Literature
go back to reference Benjamini Y, Hochberg Y (1995) Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Statist Soc B 57:289–300 Benjamini Y, Hochberg Y (1995) Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Statist Soc B 57:289–300
go back to reference Bijarnia S, Wiley V, Carpenter K, Christodoulou J, Ellaway CJ, Wilcken B (2008) Glutaric aciduria type I: outcome following detection by newborn screening. J Inherit Metab Dis 31:503–507PubMedCrossRef Bijarnia S, Wiley V, Carpenter K, Christodoulou J, Ellaway CJ, Wilcken B (2008) Glutaric aciduria type I: outcome following detection by newborn screening. J Inherit Metab Dis 31:503–507PubMedCrossRef
go back to reference Boneh A, Beauchamp M, Humphrey M, Watkins J, Peters H, Yaplito-Lee J (2008) Newborn screening for glutaric aciduria type I in Victoria: treatment and outcome. Mol Genet Metab 94:287–291PubMedCrossRef Boneh A, Beauchamp M, Humphrey M, Watkins J, Peters H, Yaplito-Lee J (2008) Newborn screening for glutaric aciduria type I in Victoria: treatment and outcome. Mol Genet Metab 94:287–291PubMedCrossRef
go back to reference Busquets C, Merinero B, Christensen E et al (2000) Glutaryl-CoA dehydrogenase deficiency in Spain: evidence of two groups of patients, genetically, and biochemically distinct. Pediatr Res 48:315–322PubMedCrossRef Busquets C, Merinero B, Christensen E et al (2000) Glutaryl-CoA dehydrogenase deficiency in Spain: evidence of two groups of patients, genetically, and biochemically distinct. Pediatr Res 48:315–322PubMedCrossRef
go back to reference Chow CW, Haan EA, Goodman SI et al (1988) Neuropathology in glutaric acidemia type 1. Acta Neuropathol 76:590–594PubMedCrossRef Chow CW, Haan EA, Goodman SI et al (1988) Neuropathology in glutaric acidemia type 1. Acta Neuropathol 76:590–594PubMedCrossRef
go back to reference Couce ML, López-Suárez O, Bóveda MD et al (2013) Glutaric aciduria type I: outcome of patients with early- versus late-diagnosis. Eur J Paediatr Neurol 74:383–389CrossRef Couce ML, López-Suárez O, Bóveda MD et al (2013) Glutaric aciduria type I: outcome of patients with early- versus late-diagnosis. Eur J Paediatr Neurol 74:383–389CrossRef
go back to reference Funk CB, Prasad AN, Frosk P et al (2005) Neuropathological, biochemical, and molecular findings in a glutaric acidemia type 1 cohort. Brain 128:711–722PubMedCrossRef Funk CB, Prasad AN, Frosk P et al (2005) Neuropathological, biochemical, and molecular findings in a glutaric acidemia type 1 cohort. Brain 128:711–722PubMedCrossRef
go back to reference Gerstner B, Gratopp A, Marcinkowski M, Sifringer M, Obladen M, Buhrer C (2005) Glutaric acid and its metabolites cause apoptosis in immature oligodendrocytes: a novel mechanism of white matter degeneration in glutaryl-CoA dehydrogenase deficiency. Pediatr Res 57:771–776PubMedCrossRef Gerstner B, Gratopp A, Marcinkowski M, Sifringer M, Obladen M, Buhrer C (2005) Glutaric acid and its metabolites cause apoptosis in immature oligodendrocytes: a novel mechanism of white matter degeneration in glutaryl-CoA dehydrogenase deficiency. Pediatr Res 57:771–776PubMedCrossRef
go back to reference Gitiaux C, Roze E, Kinugawa K et al (2008) Spectrum of movement disorders associated with glutaric aciduria type 1: a study of 16 patients. Mov Disord 23:2392–2397PubMedCrossRef Gitiaux C, Roze E, Kinugawa K et al (2008) Spectrum of movement disorders associated with glutaric aciduria type 1: a study of 16 patients. Mov Disord 23:2392–2397PubMedCrossRef
go back to reference Goodman SI, Markey SP, Moe PG, Miles BS, Teng CC (1975) Glutaric aciduria: a “new” disorder of amino acid metabolism. Biochem Med 12:12–21PubMedCrossRef Goodman SI, Markey SP, Moe PG, Miles BS, Teng CC (1975) Glutaric aciduria: a “new” disorder of amino acid metabolism. Biochem Med 12:12–21PubMedCrossRef
go back to reference Harting I, Neumaier-Probst E, Seitz A et al (2009) Dynamic changes of striatal and extrastriatal abnormalities in glutaric aciduria type I. Brain 132:1764–1782PubMedCrossRef Harting I, Neumaier-Probst E, Seitz A et al (2009) Dynamic changes of striatal and extrastriatal abnormalities in glutaric aciduria type I. Brain 132:1764–1782PubMedCrossRef
go back to reference Heringer J, Boy SPN, Ensenauer R et al (2010) Use of guidelines improves the neurological outcome in glutaric aciduria type I. Ann Neurol 68:743–752PubMedCrossRef Heringer J, Boy SPN, Ensenauer R et al (2010) Use of guidelines improves the neurological outcome in glutaric aciduria type I. Ann Neurol 68:743–752PubMedCrossRef
go back to reference Hothorn T, Hornik K, Zeileis A (2006) Unbiased recursive partitioning: a conditional inference framework. J Comput Graph Stat 15:651–674CrossRef Hothorn T, Hornik K, Zeileis A (2006) Unbiased recursive partitioning: a conditional inference framework. J Comput Graph Stat 15:651–674CrossRef
go back to reference Janos AL, Grange DK, Steiner RD, White DA (2012) Processing speed and executive abilities in children with phenylketonuria. Neuropsychology 26:735–743PubMedCentralPubMedCrossRef Janos AL, Grange DK, Steiner RD, White DA (2012) Processing speed and executive abilities in children with phenylketonuria. Neuropsychology 26:735–743PubMedCentralPubMedCrossRef
go back to reference Kölker S, Sauer SW, Surtees RA, Leonard JV (2006a) The aetiology of neurological complications of organic acidaemias—a role for the blood–brain barrier. J Inherit Metab Dis 29:701–704PubMedCrossRef Kölker S, Sauer SW, Surtees RA, Leonard JV (2006a) The aetiology of neurological complications of organic acidaemias—a role for the blood–brain barrier. J Inherit Metab Dis 29:701–704PubMedCrossRef
go back to reference Kölker S, Garbade SF, Greenberg CR et al (2006b) Natural history, outcome and therapeutic efficacy in children and adults with glutaryl-CoA dehydrogenase deficiency. Pediatr Res 59:840–847PubMedCrossRef Kölker S, Garbade SF, Greenberg CR et al (2006b) Natural history, outcome and therapeutic efficacy in children and adults with glutaryl-CoA dehydrogenase deficiency. Pediatr Res 59:840–847PubMedCrossRef
go back to reference Kölker S, Garbade SF, Boy N et al (2007) Decline of acute encephalopathic crises in children with glutaryl-CoA dehydrogenase deficiency identified by newborn screening in Germany. Pediatr Res 62:357–363PubMedCrossRef Kölker S, Garbade SF, Boy N et al (2007) Decline of acute encephalopathic crises in children with glutaryl-CoA dehydrogenase deficiency identified by newborn screening in Germany. Pediatr Res 62:357–363PubMedCrossRef
go back to reference Kölker S, Christensen E, Leonard JV et al (2011) Diagnosis and management of glutaric aciduria type I—revised recommendations. J Inherit Metab Dis 34:677–694PubMedCentralPubMedCrossRef Kölker S, Christensen E, Leonard JV et al (2011) Diagnosis and management of glutaric aciduria type I—revised recommendations. J Inherit Metab Dis 34:677–694PubMedCentralPubMedCrossRef
go back to reference Kracun I, Rösner H, Cosovic C, Stavljenic A (1984) Topographical atlas of the gangliosides of the adult human brain. J Neurochem 43:979–989PubMedCrossRef Kracun I, Rösner H, Cosovic C, Stavljenic A (1984) Topographical atlas of the gangliosides of the adult human brain. J Neurochem 43:979–989PubMedCrossRef
go back to reference Külkens S, Harting I, Sauer S et al (2005) Late-onset neurologic disease in glutaryl-CoA dehydrogenase deficiency. Neurology 64:2142–2144PubMedCrossRef Külkens S, Harting I, Sauer S et al (2005) Late-onset neurologic disease in glutaryl-CoA dehydrogenase deficiency. Neurology 64:2142–2144PubMedCrossRef
go back to reference Lamp J, Keyser B, Koeller DM, Ullrich K, Braulke T, Mühlhausen C (2011) Glutaric aciduria type 1 metabolites impair the succinate transport from astrocytes to neuronal cells. J Biol Chem 286:17777–17784PubMedCentralPubMedCrossRef Lamp J, Keyser B, Koeller DM, Ullrich K, Braulke T, Mühlhausen C (2011) Glutaric aciduria type 1 metabolites impair the succinate transport from astrocytes to neuronal cells. J Biol Chem 286:17777–17784PubMedCentralPubMedCrossRef
go back to reference Lin SK, Hsu SG, Ho ES et al (2002) Novel mutations and prenatal sonographic findings of glutaric aciduria (type I) in two Taiwanese families. Prenat Diagn 22:725–729PubMedCrossRef Lin SK, Hsu SG, Ho ES et al (2002) Novel mutations and prenatal sonographic findings of glutaric aciduria (type I) in two Taiwanese families. Prenat Diagn 22:725–729PubMedCrossRef
go back to reference Neumaier-Probst E, Harting I, Seitz A, Ding C, Kölker S (2004) Neuroradiological findings in glutaric aciduria type I (glutaryl-CoA dehydrogenase deficiency). J Inherit Metab Dis 27:869–876PubMedCrossRef Neumaier-Probst E, Harting I, Seitz A, Ding C, Kölker S (2004) Neuroradiological findings in glutaric aciduria type I (glutaryl-CoA dehydrogenase deficiency). J Inherit Metab Dis 27:869–876PubMedCrossRef
go back to reference Paradis E, Claude J, Strimmer K (2004) APE: analyses of phylogenetics and evolution in R language. Bioinformatics 20:289–290PubMedCrossRef Paradis E, Claude J, Strimmer K (2004) APE: analyses of phylogenetics and evolution in R language. Bioinformatics 20:289–290PubMedCrossRef
go back to reference Pfeil J, Listl S, Hoffmann GF, Kölker S, Lindner M, Burgard P (2013) Newborn screening by tandem mass spectrometry for glutaric aciduria type 1: a cost-effectiveness analysis. Orphanet J Rare Dis 8:167PubMedCentralPubMedCrossRef Pfeil J, Listl S, Hoffmann GF, Kölker S, Lindner M, Burgard P (2013) Newborn screening by tandem mass spectrometry for glutaric aciduria type 1: a cost-effectiveness analysis. Orphanet J Rare Dis 8:167PubMedCentralPubMedCrossRef
go back to reference R Development Core Team (2012) R: A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, ISBN 3-900051-07-0, URL http://www.R-project.org R Development Core Team (2012) R: A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, ISBN 3-900051-07-0, URL http://​www.​R-project.​org
go back to reference Sauer SW, Okun JG, Schwab MA et al (2005) Bioenergetics in glutaryl-coenzyme A dehydrogenase deficiency, a role for glutaryl-coenzyme A. J Biol Chem 280:21830–21836PubMedCrossRef Sauer SW, Okun JG, Schwab MA et al (2005) Bioenergetics in glutaryl-coenzyme A dehydrogenase deficiency, a role for glutaryl-coenzyme A. J Biol Chem 280:21830–21836PubMedCrossRef
go back to reference Sauer SW, Okun JG, Fricker G et al (2006) Intracerebral accumulation of glutaric and 3-hydroxyglutaric acids in glutaryl-coenzyme A dehydrogenase deficiency, a biochemical risk factor for neurodegeneration. J Neurochem 97:899–910PubMedCrossRef Sauer SW, Okun JG, Fricker G et al (2006) Intracerebral accumulation of glutaric and 3-hydroxyglutaric acids in glutaryl-coenzyme A dehydrogenase deficiency, a biochemical risk factor for neurodegeneration. J Neurochem 97:899–910PubMedCrossRef
go back to reference Sauer SW, Opp S, Mahringer A et al (2010) Glutaric aciduria type I and methylmalonic aciduria: simulation of cerebral import and export of accumulating neurotoxic dicarboxylic acids in in vitro models of the blood–brain barrier and the choroid plexus. Biochim Biophys Acta 1802:552–560PubMedCrossRef Sauer SW, Opp S, Mahringer A et al (2010) Glutaric aciduria type I and methylmalonic aciduria: simulation of cerebral import and export of accumulating neurotoxic dicarboxylic acids in in vitro models of the blood–brain barrier and the choroid plexus. Biochim Biophys Acta 1802:552–560PubMedCrossRef
go back to reference Sauer SW, Opp S, Hoffmann GF, Koeller DM, Okun JG, Kölker S (2011) Therapeutic modulation of cerebral L-lysine metabolism in a mouse model for glutaric aciduria type I. Brain 134:157–170PubMedCrossRef Sauer SW, Opp S, Hoffmann GF, Koeller DM, Okun JG, Kölker S (2011) Therapeutic modulation of cerebral L-lysine metabolism in a mouse model for glutaric aciduria type I. Brain 134:157–170PubMedCrossRef
go back to reference Soffer D, Amir N, Elpeleg ON et al (1992) Striatal degeneration and spongy myelinopathy in glutaric acidemia. J Neurol Sci 107:199–204PubMedCrossRef Soffer D, Amir N, Elpeleg ON et al (1992) Striatal degeneration and spongy myelinopathy in glutaric acidemia. J Neurol Sci 107:199–204PubMedCrossRef
go back to reference Strauss KA, Lazovic J, Wintermark M, Morton DH (2007) Multimodal imaging of striatal degeneration in Amish patients with glutaryl-CoA dehydrogenase deficiency. Brain 130:1905–1920PubMedCrossRef Strauss KA, Lazovic J, Wintermark M, Morton DH (2007) Multimodal imaging of striatal degeneration in Amish patients with glutaryl-CoA dehydrogenase deficiency. Brain 130:1905–1920PubMedCrossRef
go back to reference Strauss KA, Donnelly P, Wintermark M (2010) Cerebral haemodynamics in patients with glutaryl-coenzyme A dehydrogenase deficiency. Brain 133:76–92PubMedCrossRef Strauss KA, Donnelly P, Wintermark M (2010) Cerebral haemodynamics in patients with glutaryl-coenzyme A dehydrogenase deficiency. Brain 133:76–92PubMedCrossRef
go back to reference Twomey EL, Naughten ER, Donoghue VB, Ryan S (2003) Neuroimaging findings in glutaric aciduria type 1. Pediatr Radiol 33:823–830PubMedCrossRef Twomey EL, Naughten ER, Donoghue VB, Ryan S (2003) Neuroimaging findings in glutaric aciduria type 1. Pediatr Radiol 33:823–830PubMedCrossRef
go back to reference Van der Knaap MS, Valk J (2005) Myelination and retarded myelination. In: Van der Knaap MS, Valk J (eds) Magnetic resonance of myelination and myelin disorders, 3rd edn. Springer-Verlag, Berlin, pp 37–65CrossRef Van der Knaap MS, Valk J (2005) Myelination and retarded myelination. In: Van der Knaap MS, Valk J (eds) Magnetic resonance of myelination and myelin disorders, 3rd edn. Springer-Verlag, Berlin, pp 37–65CrossRef
go back to reference Viau K, Ernst SL, Vanzo RJ, Botto LD, Pasquali M, Longo N (2012) Glutaric acidemia type 1: outcomes before and after expanded newborn screening. Mol Genet Metab 106:430–438PubMedCrossRef Viau K, Ernst SL, Vanzo RJ, Botto LD, Pasquali M, Longo N (2012) Glutaric acidemia type 1: outcomes before and after expanded newborn screening. Mol Genet Metab 106:430–438PubMedCrossRef
go back to reference Venables WN, Ripley BD (2002) Modern applied statistics with S, 4th edn. Springer, New YorkCrossRef Venables WN, Ripley BD (2002) Modern applied statistics with S, 4th edn. Springer, New YorkCrossRef
go back to reference Zinnanti WJ, Lazovic J, Housman C et al (2007) Mechanism of age-dependent susceptibility and novel treatment strategy in glutaric acidemia type I. J Clin Invest 117:3258–3270PubMedCentralPubMedCrossRef Zinnanti WJ, Lazovic J, Housman C et al (2007) Mechanism of age-dependent susceptibility and novel treatment strategy in glutaric acidemia type I. J Clin Invest 117:3258–3270PubMedCentralPubMedCrossRef
Metadata
Title
Unravelling the complex MRI pattern in glutaric aciduria type I using statistical models—a cohort study in 180 patients
Authors
Sven F. Garbade
Cheryl R. Greenberg
Mübeccel Demirkol
Gülden Gökçay
Antonia Ribes
Jaume Campistol
Alberto B. Burlina
Peter Burgard
Stefan Kölker
Publication date
01-09-2014
Publisher
Springer Netherlands
Published in
Journal of Inherited Metabolic Disease / Issue 5/2014
Print ISSN: 0141-8955
Electronic ISSN: 1573-2665
DOI
https://doi.org/10.1007/s10545-014-9676-9

Other articles of this Issue 5/2014

Journal of Inherited Metabolic Disease 5/2014 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.